Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $1.1 million.

  • Outlook Therapeutics' Non-Current Assets fell 1991.63% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.8 million, marking a year-over-year decrease of 5573.23%. This contributed to the annual value of $1.2 million for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Outlook Therapeutics' Non-Current Assets stood at $1.1 million, which was down 1991.63% from $1.2 million recorded in Q3 2025.
  • Over the past 5 years, Outlook Therapeutics' Non-Current Assets peaked at $1.3 million during Q4 2024, and registered a low of $1.1 million during Q4 2025.